Search the Newsreel

Ather Energy Ltd (NSE:ATHERENERG) (Q1 2027) Earnings Call Highlights: First-Ever Positive ...

Alterity Therapeutics Adds 81,838 New Shares to ASX Listing

Alterity Therapeutics (AU:ATH) has applied to list 81,838 new ordinary fully paid shares on the ASX, a modest expansion of its equity base. This issuance stems from the exercise or conversion of existing options and aims to enhance liquidity and fund ongoing R&D, a …

Ather Energy Stock Update: Share Price Soars 13% on Strong Q1 Results

Q1 Results: DLF, SBI Funds Management, Jindal Stainless, IREDA, Torrent Power, Ather Energy, UPL, others to post earnings on August 3

Weatherford International (WFRD) Reported Lower Earnings, Is The Stock Still A Bargain?

Is Jardine Matheson Holdings (SGX:J36) Cheap On Stable Earnings, Buybacks And A Higher Dividend?

Alterity Therapeutics Quotes 81,838 Ordinary Shares Following ATHO Option Conversions

Alterity Therapeutics Limited (ASX:ATH) has applied for the quotation of 81,838 fully paid ordinary shares on the ASX, following the conversion of options (code ATHO) that expired on August 31, 2026. These new shares, issued at AUD $0.50 each, will increase the total quoted …

PRNAF SEC Filings - ALTERITY THERAPEUTICS LTD 10-K, 10-Q, 8-K Forms

This page provides a comprehensive resource for ALTERITY THERAPEUTICS LTD (PRNAF) SEC filings, including annual 10-K reports, quarterly 10-Q reports, 8-K material events, and insider trading forms. It highlights the company's focus on neurodegenerative diseases and offers details on recent filings, AI-generated summaries, impact …

Jardine Matheson Holdings Limited Just Missed Earnings - But Analysts Have Updated Their Models

Do Weatherford’s Softer Earnings and Ongoing Buybacks Reveal a Strategic Pivot for WFRD?

Euronext Athens Holding S.A. Revenue Breakdown – ATHEX:EXAE

Weatherford International Number of Employees 2026 | Employee Count & Headcount Data

Weatherford International plc (WFRD) has approximately 16,706 employees worldwide as of March 2026, marking a 1.2% decline since 2023. The company is actively hiring, with 107 job postings in 2026, though this represents a 13.1% decrease from 2025. Its workforce is concentrated in the …

ALTERITY THERAPEUTICS LIMITED: Alterity Therapeutics Releases Appendix 4C - Q4 FY26 Quarterly Cash Flow Report & Corporate Update

Alterity Therapeutics released its Q4 FY26 Quarterly Cash Flow Report and corporate update, highlighting a positive End-of-Phase 2 meeting with the FDA, which confirmed a registrational pathway for ATH434 in Multiple System Atrophy (MSA) with a single pivotal Phase 3 trial plus confirmatory evidence. …

Jardine stocks end mixed after morning gains; JMH, HKL decline, JC&C up 3.8% on special dividend

Stocks to watch: Jardine Matheson, Great Eastern, Hongkong Land, JC&C, MPACT, Seatrium, FLCT

Jardine Matheson (SGX:J36) Stock Rebound Meets A Wide Valuation Gap

WFRD|Weatherford International PLC|Price:84.700|Chg%:+2.390

TradingKey's analysis of Weatherford International PLC (WFRD) indicates healthy fundamentals and significant growth potential, although its valuation is considered fair within the Oil & Gas Related Equipment and Services industry. Institutional ownership is high, and analysts have a "Buy" rating with a target price …

Alterity Therapeutics (ATHE) Gains 1.24% to $4.5, Holding Above Key Support - Last Point Resistance

Tandy Leather Factory Inc (TLF) Financial Health: Profitability & Balance Sheet Analysis

Tandy Leather Factory Inc (TLF) has a current financial score of 4.63, placing it 36th out of 36 in the Textiles & Apparel industry, indicating weak financial status and low operating efficiency. Despite this, its latest quarterly revenue increased by 3.24% year-over-year to $19.65M, …

Alterity Therapeutics Q4 Results: FDA aligns on ATH434 Phase 3

Alterity Therapeutics announced that the FDA has agreed to a single pivotal Phase 3 trial for its lead asset, ATH434, in Multiple System Atrophy, clearing a significant regulatory hurdle. The company reported A$37.3 million in cash as of June 30, 2026, and received an …

Jardine Matheson Holdings Limited Reaffirms Earnings Guidance for the Year Ending December 31, 2026

Alterity’s ATH434 Trial for Rare MSA May Enroll 200 Patients

Alterity Therapeutics announced that the FDA has aligned on a registrational pathway for its drug ATH434 for Multiple System Atrophy (MSA), requiring a single pivotal Phase 3 trial and confirmatory evidence from its Phase 2 study. The planned Phase 3 trial will enroll approximately …

OMERS ADMINISTRATION Corp Takes Position in Weatherford International PLC $WFRD

OMERS Administration Corp. has acquired 12,400 shares of Weatherford International in Q1, valuing its new stake at approximately $1.17 million. This investment comes as institutional investors now hold 97.23% of the company's stock. Analyst sentiment remains a "Moderate Buy" despite a recent EPS miss, …

Alterity Therapeutics (NASDAQ: ATHE) outlines FDA-backed Phase 3 plan for ATH434

Alterity Therapeutics announced securing FDA alignment for a registrational pathway for its ATH434 drug in Multiple System Atrophy (MSA). The FDA agreed that a single pivotal Phase 3 trial, supported by confirmatory evidence from an ongoing Phase 2 study, could suffice for New Drug …

NCS Multistage-Weatherford Merger Expected to Close in 2H 2026

NCS Multistage (Nasdaq: NCSM) swings to Q2 loss as Weatherford buy advances

Jardine Cycle & Carriage (-JAR) Reports 11% Drop in H1 2026 Underlying Profit, Announces Special Dividend and Plans Name Change

Jardine Matheson posts 9% growth in H1 underlying profit to US$735 million

Alterity Therapeutics (NASDAQ: ATHE) sets August 31, 2026 expiry for 18.4M ATHO options

Alterity Therapeutics announced that 18,443,495 of its ATHO quoted options will expire on August 31, 2026, at 5:00 PM (AEST). The options are exercisable at $0.50 each, and official quotation on the ASX will cease on August 25, 2026. The company is also advancing …

Tandy Leather Factory Inc (TLF) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Tandy Leather Factory Inc (TLF), indicating a current valuation score of 8.95, which ranks 9th out of 36 in its industry. The company's P/E ratio is -10.36, and other valuation metrics like P/B, P/S, and P/CF have …

Alterity Therapeutics' 18.4 Million Listed Options Set to Expire 31 August 2026

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) has announced that 18,443,495 listed options (ASXC: ATHO) will expire on August 31, 2026, with an exercise price of $0.50 per share. Option holders have until August 25, 2026, to sell their options on the ASX or until …

Ather Energy Limited Revenue Breakdown – NSE:ATHERENERG

Alterity Therapeutics Ltd. Revenue Breakdown – HAM:PBN

This article provides a revenue breakdown for Alterity Therapeutics Ltd., trading under the HAM:PBN symbol on the Hamburg Stock Exchange. It highlights the availability of financial data, statements, statistics, and segment performance details for the company on the TradingView platform. The content is primarily …

Alterity Therapeutics Ltd (ATHE) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Alterity Therapeutics Ltd (ATHE), detailing its support, resistance, indicators, and moving averages. It presents a summary of various technical indicators like MACD, RSI, and KDJ, alongside moving average signals. The analysis concludes with a Neutral signal based …

Athena Resources Raises Capital Through $170,000 Share Placement at 8 Cents Per Share

Alterity Therapeutics Ltd (ATHE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article discusses the revenue breakdown of Alterity Therapeutics Ltd (ATHE), covering business segments, regional revenue, and profit contribution. However, it states that the relevant data has not been disclosed by the company yet. Therefore, no specific financial details or breakdowns are provided in …